| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Endocrine Research Laboratory, Department of Medicine, St. Lukes Medical Center, Medical College of Wisconsin (J.W.F., H.R.), Milwaukee, Wisconsin 53215; Howard Hughes Medical Institute, Departments of Medicine and Genetics, Boyer Center for Molecular Medicine, Yale University School of Medicine (J.H.H., R.P.L.), New Haven, Connecticut 06510
Address all correspondence and requests for reprints to: James W. Findling, M.D., Department of Medicine, St. Lukes Health Science Office Building, 2901 West KK River Parkway, Suite 503, Milwaukee, Wisconsin 53215.
Liddles syndrome is an autosomal dominant form of hypertension that
resembles primary hyperaldosteronism, is characterized by the early
onset of hypertension with hypokalemia and suppression of both PRA and
aldosterone, and is caused by mutations in the carboxyl-terminus of the
ß- or
-subunits of the renal epithelial sodium channel. We
describe a kindred (K176) whose distinguishing clinical features were
mild hypertension and decreased aldosterone secretion. The index case
was a 16-yr-old girl with intermittent mild hypertension and
hypokalemia and subnormal PRA, aldosterone, 18-hydroxycorticosterone,
and deoxycortisol levels, but normal cortisol/cortisone metabolite
ratio and cortisol half-life. A frameshift mutation in the
carboxyl-terminus of the ß-subunit of the epithelial sodium channel
was identified in the index case, establishing the diagnosis of
Liddles syndrome. Sixteen at-risk relatives of the index case were
tested. Seven new subjects were heterozygous for the mutation found in
the index case, and two deceased obligate carriers were identified. All
genetically affected adult subjects had a history of mild hypertension,
and four had a history of hypokalemia. Basal and postcosyntropin plasma
aldosterone and urinary aldosterone levels were significantly
suppressed in those positive for the mutation. The family demonstrates
variability in the severity of hypertension and hypokalemia in this
disease, raising the possibility that this disease may be
underdiagnosed among patients with essential hypertension.
This article has been cited by other articles:
![]() |
O. A. Carretero and S. Oparil Essential Hypertension : Part I: Definition and Etiology Circulation, January 25, 2000; 101(3): 329 - 335. [Full Text] [PDF] |
||||
![]() |
D. V Milford Investigation of hypertension and the recognition of monogenic hypertension Arch. Dis. Child., November 1, 1999; 81(5): 452 - 455. [Full Text] [PDF] |
||||
![]() |
W. T. Ambrosius, L. J. Bloem, L. Zhou, J. F. Rebhun, P. M. Snyder, M. A. Wagner, C. Guo, and J. H. Pratt Genetic Variants in the Epithelial Sodium Channel in Relation to Aldosterone and Potassium Excretion and Risk for Hypertension Hypertension, October 1, 1999; 34(4): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Pratt and V. J. Dzau Genomics and Hypertension : Concepts, Potentials, and Opportunities Hypertension, January 1, 1999; 33(1): 238 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Melander, M. Orho, J. Fagerudd, K. Bengtsson, P.-H. Groop, I. Mattiasson, L. Groop, and U. L. Hulthen Mutations and Variants of the Epithelial Sodium Channel Gene in Liddle's Syndrome and Primary Hypertension Hypertension, May 1, 1998; 31(5): 1118 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Litchfield, B. F. Anderson, R. J. Weiss, R. P. Lifton, and R. G. Dluhy Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism Hypertension, January 1, 1998; 31(1): 445 - 450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |